Mandatory notification of trade and disclosure of large shareholding

25. Aug 2021 | 1 min read

Vatne Equity AS, a closely related party of Runar Vatne, Board Member of Gentian
Diagnostics ASA, has today purchased 100,000 shares in Gentian Diagnostics ASA
at a price of NOK 67.2174 per share. After the transaction Vatne Equity AS and
closely related parties of Runar Vatne owns 2,337,224 shares Gentian Diagnostics
ASA corresponding to 15.17% of the outstanding shares and voting rights.

This information is subject to the disclosure requirements pursuant to MAR and
Section 5-12 of the Norwegian Securities Trading Act and the Norwegian
Securities Trading Act 4-2 as regards to the disclosure of large shareholding.


 

  540725_GDASA - KRT-1500_Runar Vatne.pdf

You may also read


Oct 21, 2021 - Kristin Hart

Third quarter 2021 report

Moss, 21 October 2021: Gentian Diagnostics ASA, a fast-growing developer and manufacturer of diagnostic..

Oct 12, 2021 - Kristin Hart

Flaggemelding

Obligasjon 2 AS har 5. oktober 2021 kjøpt 85 000 aksjer i Gentian Diagnostics ASA til gjennomsnittlig pris..